• Thursday, April 18, 2019 @ 10:30 am

BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Qatar Biobank. BC Platforms will provide a Research Collaboration Management System (RCMS) and Researchers’ Portal for Qatar Biobank to support the integration of genomic and phenotypic samples, enable secure and streamlined data access, and optimize resource quality and utilization. The agreement supports a vision of personalized healthcare to Qatar’s population and beyond

Qatar Biobank, a member of Qatar Foundation (QF) and part of QF Research, Development and Innovation (QF RDI), collects data and biological samples from the local population in an effort to develop customized medical solutions to the various diseases and health issues prevalent in the country.

Dr. Nahla Afifi, Director of Qatar Biobank, said: “As the Qatar National Research Strategy strives to improve the health and well-being of Qatar’s population, scientific research collaborations enabled by Qatar Biobank are the key to impacting the future of personalised healthcare in Qatar and the region.”

“We are delighted to partner with BC Platforms to access their multi-omics technology capabilities to leverage our data for research and ultimately to bring benefits to patients. Through our efforts, we will enable researchers to discover how the health and genetics of Qatar’s population are affected by their lifestyle and environment.”

BC Platforms has over 20 years of experience in building tertiary analytics tools enabling scalable phenotypic and genetic data exploration, applied by customers in over 25 countries. Recent developments include ontology browsing and data visualization dashboards which provide users with a visual and contextual overview of massive datasets, customizable to researchers’ needs.

Tero Silvola, CEO of BC Platforms, stated: “One of the big focus areas in technology related development work is associated with available capabilities to analyse all different types of data together. Qatar Biobank is a globally unique resource and is considered to be one of the leading personalised medicine programs globally. We are delighted to support Qatar Biobank in achieving its goals in biomedical research both regionally and globally.”

Qatar Biobank has incubated Qatar Genome Programme (QGP), another member of QF and part of QF RDI, which is a national initiative aiming to map the genome of the local population. QGP uses a collection of samples and data from Qatar Biobank participants to identify genotype-phenotype associations relevant to the Qatari population. 

You may also be interested in